## Abstract ## Background Topical negative pressure (TNP) therapy is becoming increasingly popular for all kinds of wounds. Its clinical and cost effectiveness is unclear. ## Methods A search of randomized controlled trials (RCTs) on TNP in adult patients with all kinds of wounds in all settings
Development of a biodegradable foam for use in negative pressure wound therapy
β Scribed by Jie Liu; Michael J. Morykwas; Louis C. Argenta; William D. Wagner
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 425 KB
- Volume
- 98B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Treatment of wounds using negative pressure wound therapy (NPWT) uses a nondegradable polyvinyl alcohol (PVA) foam in the application of negative pressures typically for 1β3 days. The purpose of this study was to construct and test biodegradable poly(Ξ΅βcaprolactone) (PCL) foam as a substitute for the PVA foam. Such a foam would be left within the wound until healing was achieved and form a biodegradable matrix into which tissue would grow. The use of such foam would obviate the need for any serial foam changes and a final foam removal, thus making patient care much easier and more economical. PCL foams were prepared by salt leaching and phase separation. Morphological and mechanical properties of the foams were characterized and compared to PVA foam. PCL and PVA foams were tested on the uncut surface of a pig liver maintained in a hydration chamber continuously replenished with saline under the conditions of negative pressure of 50 mm Hg for 72 h. The results demonstrated that PCL foam made from phase separation had the similar properties and function as the PVA foam. The results demonstrate that PCL foam is an appropriate substitute for currently used nondegradable PVA foam in NPWT applications. Β© 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2011.
π SIMILAR VOLUMES
## Abstract Among other side effects, administration of anticancer agents is accompanied by manifestations of gastrointestinal toxicity and disturbances of antioxidant balance. The monitoring of these toxic effects in clinical practice is impeded by a dearth of reliable laboratory methods. Therefor